COVID-19: collaboration will keep us ahead of the curve

Pallavi Shamdasani¹, Jason A Trubiano^{2

3

4}, Olivia C Smibert^{2

3

4}, Claire E Owen^{1

3}, David F L Liew^{1

3

5}

Affiliations

¹ Department of Rheumatology, Austin Health, Melbourne, Victoria, Australia.
² COVID Unit, Department of Infectious Diseases, Austin Health, Melbourne, Victoria, Australia.
³ Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
⁴ The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁵ Department of Clinical Pharmacology and Therapeutics, Austin Health, Melbourne, Victoria, Australia.

Editorial

Pallavi Shamdasani et al. Intern Med J. 2020 Jul.

. 2020 Jul;50(7):784-786.

doi: 10.1111/imj.14888.

Pallavi Shamdasani¹, Jason A Trubiano^{2

3

4}, Olivia C Smibert^{2

3

4}, Claire E Owen^{1

3}, David F L Liew^{1

3

5}

¹ Department of Rheumatology, Austin Health, Melbourne, Victoria, Australia.
² COVID Unit, Department of Infectious Diseases, Austin Health, Melbourne, Victoria, Australia.
³ Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
⁴ The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
⁵ Department of Clinical Pharmacology and Therapeutics, Austin Health, Melbourne, Victoria, Australia.

No abstract available

Comment on

COVID-19: immunopathology and its implications for therapy.
Cao X. Cao X. Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3. Nat Rev Immunol. 2020. PMID: 32273594 Free PMC article.
Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies.
Zhou G, Chen S, Chen Z. Zhou G, et al. Front Med. 2020 Apr;14(2):117-125. doi: 10.1007/s11684-020-0773-x. Epub 2020 Apr 21. Front Med. 2020. PMID: 32318975 Free PMC article. Review.

1. Zhou G, Chen S, Chen Z. Advances in COVID‐19: the virus, the pathogenesis, and evidence‐based control and therapeutic strategies. Front Med 2020; 14: 117–125. - PMC - PubMed
1. Cao X. COVID‐19: immunopathology and its implications for therapy. Nat Rev Immunol 2020; 20: 269–70. - PMC - PubMed
1. Pedersen SF, Ho YC. SARS‐CoV‐2: a storm is raging. J Clin Invest 2020; 130: 2202–5. - PMC - PubMed
1. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID‐19): a review. JAMA 2020; 323: 1824–36. - PubMed
1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–9. - PMC - PubMed